Sandal fragrances
    52.
    发明授权
    Sandal fragrances 失效
    凉鞋香水

    公开(公告)号:US07368613B2

    公开(公告)日:2008-05-06

    申请号:US11422917

    申请日:2006-06-08

    Applicant: Marcus Eh

    Inventor: Marcus Eh

    Abstract: A compound of formula (Ia) or (Ib), wherein in each of formulae (Ia) and (Ib) R1 and R2, independently of one another, are H or CH3, and the use thereof as a sandalwood fragrance.

    Abstract translation: 式(Ia)或(Ib)的化合物,其中在式(Ia)和(Ib)的每一个中,R 1和R 2彼此独立地为 H或CH 3 3,以及其作为檀香香料的用途。

    Methods of treating osteoporosis prophylactically or therapeutically
    53.
    发明授权
    Methods of treating osteoporosis prophylactically or therapeutically 失效
    预防或治疗骨质疏松症的方法

    公开(公告)号:US5801164A

    公开(公告)日:1998-09-01

    申请号:US480310

    申请日:1995-06-07

    Abstract: Methods of treating osteoporosis prophylactically or therapeutically are disclosed. The method of treating osteoporosis includes administering to a patient suffering therefrom an effective amount to treat the osteoporosis of novel 1.alpha.-hydroxyvitamin D.sub.4 and novel analogues 1,25-dihydroxyvitamin D.sub.4 and 1,24-dihydroxyvitamin D.sub.4, the aforementioned compounds having lower toxicity as measured by an LD.sub.50 test in rats when compared to a corresponding vitamin D.sub.3 compound. The method of administering the compound is substantially without occurrence of hypercalcemia.

    Abstract translation: 公开了预防或治疗骨质疏松症的方法。 治疗骨质疏松症的方法包括向患有其的患者施用有效量的治疗新型1α-羟基维生素D4和新型类似物1,25-二羟基维生素D4和1,24-二羟基维生素D4的骨质疏松症,上述具有较低毒性的化合物 与相应的维生素D3化合物相比,通过LD50测试在大鼠中测量。 施用化合物的方法基本上不发生高钙血症。

    1.alpha.-hydroxy vitamin D.sub.4 and novel intermediates and analogues
    56.
    发明授权
    1.alpha.-hydroxy vitamin D.sub.4 and novel intermediates and analogues 失效
    1α-羟基维生素D4和新型中间体和类似物

    公开(公告)号:US5488120A

    公开(公告)日:1996-01-30

    申请号:US296084

    申请日:1994-08-24

    CPC classification number: A61K31/592 C07C35/21 C07C401/00

    Abstract: Novel 1.alpha.-hydroxy Vitamin D.sub.4 and novel analogues, 1,25 dihydroxy Vitamin D.sub.4 and 1,24 dihydroxy Vitamin D.sub.4 which are useful for the treatment of disorders of calcium metabolism. Preparation of the novel 1.alpha.-hydroxy Vitamin D.sub.4 starts from ergosterol which is converted in six steps to 22,23-dihydroergosterol. 22,23-dihydroergosterol was irradiated to yield Vitamin D.sub.4 which was converted in four steps to 1.alpha.-hydroxy Vitamin D.sub.4 using a cyclovitamin procedure which produced the novel intermediates, Vitamin D.sub.4 tosylate, 3,5 cyclovitamin D.sub.4 and 1.alpha.-hydroxy cyclovitamin D.sub.4. 1,25 dihydroxy Vitamin D.sub.4 and 1,24 dihydroxy Vitamin D.sub.4 are isolated as biological products of the metabolism of novel 1.alpha.-hydroxy Vitamin D.sub.4 using cultured human liver cells.

    Abstract translation: 新型1α-羟基维生素D4和新型类似物,1,25二羟基维生素D4和1,24二羟基维生素D4,其可用于治疗钙代谢紊乱。 新型1α-羟基维生素D4的制备从麦角甾醇开始,其以六步转化为22,23-二氢麦角甾醇。 22,23-二氢麦角甾醇被照射以产生维生素D4,其使用产生新的中间体维生素D4甲苯磺酸盐,3,5环维生素D4和1α-羟基环维生素D4的环维生素程序将其四步转化为1α-羟基维生素D4 。 使用培养的人肝细胞,分离出1,25二羟基维生素D4和1,24二羟基维生素D4作为新型1α-羟基维生素D4代谢的生物学产物。

Patent Agency Ranking